Filing Details
- Accession Number:
- 0001209191-19-045553
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-12 17:27:00
- Reporting Period:
- 2019-08-09
- Accepted Time:
- 2019-08-12 17:27:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1123494 | Harvard Bioscience Inc | HBIO | Laboratory Analytical Instruments (3826) | 043306140 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721318 | A. Katherine Eade | C/O Harvard Bioscience, Inc. 84 October Hill Rd. Holliston MA 01746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-09 | 39,915 | $2.48 | 121,515 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes (a) a deferred stock award of 1,100 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019 as described in footnote 1 above; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 6,350 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 78,965 shares of common stock beneficially owned by the Reporting Person.
Billionaire Hedge Funds
